CAS 1446090-79-4

Lifirafenib

CAS: 1446090-79-4

Lifirafenib

Reinheit: ≥98%

Molekulargewicht: 478.42g/mol

Ref: 54-BUP03697

Lifirafenib

CAS: 1446090-79-4

Lifirafenib is a potent and selective kinase inhibitor, which is synthetically derived. It operates by targeting and inhibiting specific pathways involving the RAF kinases within the MAPK/ERK signaling cascade. This interruption is critical in the control of cellular proliferation and survival, pathways often dysregulated in various cancers. Lifirafenib is particularly effective against BRAF-mutant cancers, including melanoma and certain types of thyroid and colorectal cancers.

Formel: C₂₅H₁₇F₃N₄O₃

Reinheit: Min. 95%

Molekulargewicht: 478.42 g/mol

Ref: 3D-WHC09079

Lifirafenib

CAS: 1446090-79-4

Lifirafenib (Beigene-283) is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495 nM for the recombinant

Formel: C₂₅H₁₇F₃N₄O₃

Reinheit: 97.99% - 98%

Farbe und Form: Solid

Molekulargewicht: 478.42

Ref: TM-T22272